D Chesov
Overview
Explore the profile of D Chesov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kirakosyan O, Reimann M, Andersen A, Bjarnason A, Bakos A, Dyrhol-Riise A, et al.
IJTLD Open
. 2025 Feb;
2(2):101-106.
PMID: 39959402
Background: Anecdotal information suggests that clinical practice regarding the use of putative hepatoprotective agents in TB treatment varies across countries in the WHO European Region. Methods: Between November 2023 and...
2.
National survey on the impact of the war in Ukraine on TB diagnostics and treatment services in 2022
Butov D, Feshchenko Y, Chesov D, Myasoedov V, Kuzhko M, Dudnyk A, et al.
Int J Tuberc Lung Dis
. 2023 Feb;
27(1):86-88.
PMID: 36853139
No abstract available.
3.
Chesov D, Makhanda G, Furin J
Int J Tuberc Lung Dis
. 2021 Nov;
25(9):683-684.
PMID: 34802485
No abstract available.
4.
Migliori G, Marx F, Ambrosino N, Zampogna E, Schaaf H, van der Zalm M, et al.
Int J Tuberc Lung Dis
. 2021 Oct;
25(10):797-813.
PMID: 34615577
Increasing evidence suggests that post-TB lung disease (PTLD) causes significant morbidity and mortality. The aim of these clinical standards is to provide guidance on the assessment and management of PTLD...
5.
Chesov D, Butov D, Reimann M, Heyckendorf J, Myasoedov V, Butov T, et al.
Int J Tuberc Lung Dis
. 2021 Mar;
25(4):277-284.
PMID: 33762071
The potential association between the lung function status at baseline and TB treatment outcome has not been evaluated previously. We aimed to investigate the impact of lung function status at...
6.
Chesov D, Lesanu V, Ciobanu N, Codreanu A, Crudu V, Cuevas L, et al.
Int J Tuberc Lung Dis
. 2020 Oct;
24(10):1103-1105.
PMID: 33126946
No abstract available.
7.
Butov D, Lange C, Heyckendorf J, Kalmykova I, Butova T, Borovok N, et al.
Int J Tuberc Lung Dis
. 2020 May;
24(5):485-491.
PMID: 32398197
To document the level of drug resistance in MDR-TB patients and to characterize management capacities for their medical care and MDR-TB treatment outcomes in the Kharkiv region of Ukraine. This...
8.
Chesov D, Lange C, Heyckendorf J
Int J Tuberc Lung Dis
. 2019 Sep;
23(8):879-880.
PMID: 31533876
No abstract available.
9.
Lange C, Aarnoutse R, Alffenaar J, Bothamley G, Brinkmann F, Costa J, et al.
Int J Tuberc Lung Dis
. 2019 Jul;
23(6):645-662.
PMID: 31315696
The emergence of multidrug-resistant tuberculosis (MDR-TB; defined as resistance to at least rifampicin and isoniazid) represents a growing threat to public health and economic growth. Never before in the history...
10.
Chesov D, Alexandru S, Crudu V, Ciobanu N, Botnaru V, Heyckendorf J, et al.
Int J Tuberc Lung Dis
. 2019 May;
23(4):522-524.
PMID: 31064633
No abstract available.